Tokyo, Japan

Noriko Ishiguro

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriko Ishiguro. Retrieved from https://idiyas.com/inventor/noriko-ishiguro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Noriko Ishiguro: Innovator in Medicinal Chemistry

Introduction

Noriko Ishiguro is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic applications. Her work has led to the filing of multiple patents, showcasing her innovative approach to drug discovery.

Latest Patents

Noriko Ishiguro holds 2 patents that focus on nitrogen-containing 6-membered cyclic compounds. These compounds are represented by a specific general formula and have demonstrated superior EPreceptor agonist activity. The medicaments containing these compounds or their salts serve as active ingredients that can promote osteogenesis and aid in the therapeutic treatment and healing of fractures.

Career Highlights

Ishiguro is currently affiliated with Asahi Kasei Pharma Corporation, where she continues to advance her research in medicinal chemistry. Her work is characterized by a commitment to developing innovative solutions for medical challenges.

Collaborations

Noriko collaborates with esteemed colleagues, including Daisuke Shikanai and Osamu Omori. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Noriko Ishiguro is a trailblazer in the field of medicinal chemistry, with a focus on innovative compounds that have the potential to improve patient outcomes. Her contributions through patents and collaborations reflect her dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…